Symbol
|
MZPLTQ | P319TQ | P308TQ | NGFLTQ | P322TQ | VDALTQ | VBMLTQ | VXULTQ | WEVLTQ | RMASRV | RMAJLV | WXNLTQ | EOJRCH | RMABXV | ICOEFG | NELRCH | YOTLTQ | NPYRCH | RMBWDV | RMAVSV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Multi Vonti | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti |
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / Zurich | Novartis / Roche GS / Swiss Life / Zurich | Nestlé / Novartis / Roche GS | Novartis AG / Sika AG / Swisscom N / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim AG / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
07.07.2025 | 08.09.2025 | 07.10.2025 | 07.10.2025 | 23.12.2025 | 16.09.2025 | 30.09.2025 | 11.07.2025 | 31.03.2028 | 10.02.2026 | 10.06.2025 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 03.11.2028 | 03.11.2025 | 24.11.2027 | 02.02.2026 | 27.07.2026 | 23.02.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Prix d'exercise
|
83,94 | 86,91 | 87,47 | 87,47 | 80,46 | 212,30 | 53,41 | 322,02 | 11,22 | 183,53 | 86,32 | 276,12 | 287,84 | 77,13 | - | 455,84 | 74,2425 | 166,842 | 282,20 | 47,42 |
rendement max. p.a. | 26,80% | 18,27% | 16,17% | 14,50% | 5,87% | -1,42% | -1,29% | 10,22% | 3,95% | 3,95% | 41,04% | 5,55% | 4,86% | 5,69% | - | 1,40% | 4,44% | 5,62% | 6,42% | 19,03% |
Demande | 99,54 | 97,24 | 96,66 | 97,25 | 98,58 | 101,02 | 100,71 | 99,52 | 100,51 | 99,30 | 98,90 | 95,44 | 100,19 | - | 105,55 | 101,64 | 100,52 | 99,56 | 98,50 | 90,20 |
Offre | 100,34 | 98,04 | 97,46 | 98,05 | 99,38 | 101,83 | 101,52 | 100,32 | 101,32 | 100,90 | 101,30 | 96,24 | 100,99 | - | - | 102,46 | 101,33 | 100,36 | 100,10 | 91,60 |